Lyell Wealth Management LP Has $2.08 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

by · The Markets Daily

Lyell Wealth Management LP grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 1.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 21,067 shares of the exchange traded fund’s stock after purchasing an additional 366 shares during the quarter. Lyell Wealth Management LP’s holdings in SPDR S&P Biotech ETF were worth $2,081,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of XBI. Brookstone Capital Management acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter valued at $284,000. Wealthcare Advisory Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter valued at $257,000. Wealth Enhancement Advisory Services LLC lifted its stake in shares of SPDR S&P Biotech ETF by 8.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 114,633 shares of the exchange traded fund’s stock valued at $10,878,000 after acquiring an additional 9,383 shares during the period. 180 Wealth Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 42.6% during the first quarter. 180 Wealth Advisors LLC now owns 3,952 shares of the exchange traded fund’s stock valued at $375,000 after acquiring an additional 1,181 shares during the period. Finally, Financial Management Professionals Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 34.3% during the first quarter. Financial Management Professionals Inc. now owns 1,061 shares of the exchange traded fund’s stock valued at $101,000 after acquiring an additional 271 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1 %

Shares of XBI opened at $97.15 on Friday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm has a market capitalization of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11. The stock’s fifty day simple moving average is $99.14 and its 200-day simple moving average is $94.60.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More